NovelStem International Corp.
NSTM · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.01 | -0.00 | 0.33 | -0.07 |
| FCF Yield | -75.49% | -12.38% | -2.07% | -1.46% |
| EV / EBITDA | -1.80 | -1.67 | -21.53 | 0.00 |
| Quality | ||||
| ROIC | 127.76% | -163.39% | -19.00% | -53.02% |
| Gross Margin | 100.00% | 100.00% | 100.00% | 0.00% |
| Cash Conversion Ratio | 0.08 | 0.08 | 0.24 | 0.13 |
| Growth | ||||
| Revenue 3-Year CAGR | 0.00% | – | – | -100.00% |
| Free Cash Flow Growth | 21.91% | -91.03% | -0.77% | -143.15% |
| Safety | ||||
| Net Debt / EBITDA | -1.67 | -0.93 | -0.67 | 0.00 |
| Interest Coverage | -2.18 | -35.61 | -38.30 | -72.61 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 319.37 | 0.00 | 365.00 | 0.00 |